India cracks down on clinics offering stem cell therapy and blood cord banking

India cracks down on clinics offering stem cell therapy and blood cord banking

The Indian government has updated national guidelines on stem cell research to help curb the indiscriminate use of stem cells in a range of conditions with no evidence. The revisions come amid concerns that several private clinics in India claim to offer stem cell therapies for autism, cerebral pals...

Full description

Saved in:
Bibliographic Details
Published in:BMJ (Online) Vol. 358; p. j3639
Main Author: Dutta, Sumi S
Format: Journal Article
Language:English
Published: England BMJ Publishing Group LTD 27-07-2017
Subjects:
Autism
Blood banks
Blood Banks - standards
Cirrhosis
Clinical trials
Coronary artery disease
Councils
Dementia disorders
Diabetes mellitus
Fetal Blood
Heart diseases
Humans
India
Liver cirrhosis
Liver diseases
Medical research
Paralysis
Practice Guidelines as Topic
Private Sector - standards
Regulatory approval
Stem Cell Transplantation - standards
Stem cells
Stroke
India
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Indian government has updated national guidelines on stem cell research to help curb the indiscriminate use of stem cells in a range of conditions with no evidence. The revisions come amid concerns that several private clinics in India claim to offer stem cell therapies for autism, cerebral palsy, heart disease, diabetes, dementia, liver cirrhosis, learning disabilities, and stroke, among other conditions. Geeta Jotwani, ICMR deputy director general, told The BMJ, "These new guidelines seek...
Bibliography:SourceType-Other Sources-1
ObjectType-News-1
content type line 66
ISSN:0959-8138
1756-1833
DOI:10.1136/bmj.j3639